Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405
Abstract
The incidence of young-onset colorectal cancer (yoCRC) is increasing. It is unknown if there are survival differences between young and older patients with metastatic colorectal cancer (mCRC).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 12, 2021
- Source ID
- 10.1093/jnci/djab200
Entities
People
- Alan P Venook
- Andrew B Nixon
- Chao Ma
- Charles D Blanke
- Charles S. Fuchs
- Donna Niedzwiecki
- Eileen M. O'Reilly
- Fang-Shu Ou
- Federico Innocenti
- Heinz-josef Lenz
- I-wen Chang
- Jeffrey A Meyerhardt
- Katherine Van Loon
- Kimmie Ng
- Marla Lipsyc-Sharf
- Nadine Jackson Mccleary
- Richard M Goldberg
- Robert J. Mayer
- Sorbarikor Piawah
- Sui Zhang
- Tiffany M Bainter
Organizations
- Alliance for Clinical Trials in Oncology
- Bristol-Myers Squibb
- Dana–Farber Cancer Institute
- Duke University
- Genentech
- Johns Hopkins Bloomberg School of Public Health
- Mayo Clinic
- National Cancer Institute
- Oregon Health & Science University
- Pfizer
- Roche (United States)
- Sanofi-Aventis
- United States Department of Defense
- University of California, San Francisco
- University of North Carolina at Chapel Hill
- University of Southern California
- Weill Cornell Medicine
- West Virginia University
- Yale Cancer Center